Agreed. Tend to place the RX Safe in the Mainstream and Retail.I would categorize other products RXSF has as Healthcare. I sort of understand why all the PR's are needed to keep RXSF PPS up and make a market, but as you say the Seasoned Healthcare Investor knows the risk and doesn't worry about the PPS. I don't totally agree with your Biotech analogy, as I see this more of a blend with healthcare, but fully understand what your saying.
How soon before RXSF concentrates on another product, or do we need funding first?
News 
Market Data 
Discover 
AI
